Torsten Lauritzen
Overview
Explore the profile of Torsten Lauritzen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
180
Citations
9335
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Knudsen J, Knudsen S, Hulman A, Witte D, Gregg E, Lauritzen T, et al.
Lancet Reg Health Eur
. 2022 Jan;
14:100291.
PMID: 35024680
Background: In 2011, the World Health Organization began recommending glycated haemoglobin (HbA) as a measure for diagnosing type 2 diabetes (T2D). This initiative may have changed basic T2D epidemiology. Consequently,...
2.
Ronn P, Andersen G, Lauritzen T, Christensen D, Aadahl M, Carstensen B, et al.
BMJ Open
. 2020 Sep;
10(9):e038071.
PMID: 32928857
Objectives: Abdominal fat has been identified as a risk marker of cardiometabolic disease independent of overall adiposity. However, it is not clear whether there are ethnic disparities in this risk....
3.
Orts L, Bech B, Lauritzen T, Thomsen J, Bruun N, Lokke A, et al.
BJGP Open
. 2020 Aug;
4(4).
PMID: 32753558
Background: Spirometry is essential to identify cases with obstructive lung diseases (OLDs) in primary care. However, knowledge about the long-term prognostic outcome among younger individuals is sparse. Aim: To describe...
4.
Jensen M, Lauritzen T, Vilstrup H, Jepsen P
Clin Epidemiol
. 2020 Apr;
12:345-351.
PMID: 32280278
Purpose: Alanine aminotransferase is the most frequently used marker of liver cell injury. We examined the association between alanine aminotransferase levels and long-term absolute risks of morbidity and mortality in...
5.
Orts L, Bech B, Lauritzen T, Carlsen A, Sandbaek A, Lokke A
NPJ Prim Care Respir Med
. 2020 Mar;
30(1):10.
PMID: 32218439
Spirometry is recommended in symptomatic smokers to identify obstructive lung diseases. However, it is unknown whether there are certain characteristics that can be used to identify the individual risk of...
6.
Clemmensen K, Quist J, Vistisen D, Witte D, Jonsson A, Pedersen O, et al.
Endocr Connect
. 2020 Mar;
9(4):279-288.
PMID: 32163918
Fasting duration has been associated with lower fasting blood glucose levels, but higher 2-h post-load levels, and research has indicated an adverse effect of 'weekend behavior' on human metabolism. We...
7.
Charles M, Bruun N, Simmons R, Dalsgaard E, Witte D, Jorgensen M, et al.
BJGP Open
. 2020 Feb;
4(1).
PMID: 32071038
Background: There is no long-term evidence on the effectiveness of training for motivational interviewing in diabetes treatment. Aim: Within a trial of intensive treatment of people with screen-detected diabetes, which...
8.
Janus C, Vistisen D, Amadid H, Witte D, Lauritzen T, Brage S, et al.
Endocr Connect
. 2019 Dec;
8(12):1607-1617.
PMID: 31804964
Rationale: The hormone glucagon-like peptide-1 (GLP-1) decreases blood glucose and appetite. Greater physical activity (PA) is associated with lower incidence of type 2 diabetes. While acute exercise may increase glucose-induced...
9.
Knudsen J, Hulman A, Ronn P, Lauritzen T, Sorensen H, Witte D, et al.
Diabetes Care
. 2019 Dec;
43(2):e17-e19.
PMID: 31796572
No abstract available.
10.
Griffin S, Rutten G, Khunti K, Witte D, Lauritzen T, Sharp S, et al.
Lancet Diabetes Endocrinol
. 2019 Nov;
7(12):925-937.
PMID: 31748169
Background: The multicentre, international ADDITION-Europe study investigated the effect of promoting intensive treatment of multiple risk factors among people with screen-detected type 2 diabetes over 5 years. Here we report...